Literature DB >> 17501888

Cancer stem cells: a review.

John B Spillane1, Michael A Henderson.   

Abstract

Research has been increasing in recent years into the application of stem cell biology to clinical medicine, particularly its role in the evolution and metastasis of tumours. Stem cells may be the target cell for malignant transformation, and tumour formation could be considered a disorder of stem cell self-renewal pathways. Cancer stem cells have been identified in acute myeloid leukaemia and in breast and central nervous system tumours. Cancer stem cells may have a specific role in tumour metastasis, and their understanding may provide insights into the development of predictive and prognostic markers and specific therapeutic interventions.

Entities:  

Mesh:

Year:  2007        PMID: 17501888     DOI: 10.1111/j.1445-2197.2007.04096.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  27 in total

1.  Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.

Authors:  Alireza Mirzaei; Gholamreza Tavoosidana; Mohammad Hossein Modarressi; Afshin Abdi Rad; Mohammad Sadegh Fazeli; Reza Shirkoohi; Masoumeh Tavakoli-Yaraki; Zahra Madjd
Journal:  Tumour Biol       Date:  2015-01-29

2.  Emodin as an effective agent in targeting cancer stem-like side population cells of gallbladder carcinoma.

Authors:  Xin-xing Li; Ying Dong; Wei Wang; Hao-lu Wang; Yu-ying Chen; Gui-ying Shi; Jing Yi; Jian Wang
Journal:  Stem Cells Dev       Date:  2012-11-07       Impact factor: 3.272

3.  Wnt signaling regulates the stemness of lung cancer stem cells and its inhibitors exert anticancer effect on lung cancer SPC-A1 cells.

Authors:  Xueyan Zhang; Yuqing Lou; Huimin Wang; Xiaoxuan Zheng; Qianggang Dong; Jiayuan Sun; Baohui Han
Journal:  Med Oncol       Date:  2015-03-03       Impact factor: 3.064

4.  Overactivation of Ras signaling pathway in CD133+ MPNST cells.

Authors:  Emma Borrego-Diaz; Kaoru Terai; Kristina Lialyte; Amanda L Wise; Tuba Esfandyari; Fariba Behbod; Victor F Mautner; Melanie Spyra; Sarah Taylor; Luis F Parada; Meena Upadhyaya; Faris Farassati
Journal:  J Neurooncol       Date:  2012-04-08       Impact factor: 4.130

Review 5.  The role of histone modifications and variants in regulating gene expression in breast cancer.

Authors:  Mathieu Dalvai; Kerstin Bystricky
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-02-04       Impact factor: 2.673

Review 6.  In search of liver cancer stem cells.

Authors:  Stephanie Ma; Kwok Wah Chan; Xin-Yuan Guan
Journal:  Stem Cell Rev       Date:  2008-07-29       Impact factor: 5.739

7.  Transdifferentiation-inducing HCCR-1 oncogene.

Authors:  Seon-Ah Ha; Hyun K Kim; JinAh Yoo; SangHee Kim; Seung M Shin; Youn S Lee; Soo Y Hur; Yong W Kim; Tae E Kim; Yeun J Chung; Shin S Jeun; Dong W Kim; Yong G Park; Jin Kim; Soon Y Shin; Young H Lee; Jin W Kim
Journal:  BMC Cell Biol       Date:  2010-06-30       Impact factor: 4.241

8.  The Role of chemokine receptor CXCR4 in breast cancer metastasis.

Authors:  Debarati Mukherjee; Jihe Zhao
Journal:  Am J Cancer Res       Date:  2013-01-18       Impact factor: 6.166

9.  G-protein-coupled receptor GPR49 is up-regulated in basal cell carcinoma and promotes cell proliferation and tumor formation.

Authors:  Keiji Tanese; Mariko Fukuma; Taketo Yamada; Taisuke Mori; Tsutomu Yoshikawa; Wakako Watanabe; Akira Ishiko; Masayuki Amagai; Takeji Nishikawa; Michiie Sakamoto
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

10.  Spheres derived from lung adenocarcinoma pleural effusions: molecular characterization and tumor engraftment.

Authors:  Rita Mancini; Enrico Giarnieri; Claudia De Vitis; Donatella Malanga; Giuseppe Roscilli; Alessia Noto; Emanuele Marra; Carmelo Laudanna; Pietro Zoppoli; Pasquale De Luca; Andrea Affuso; Luigi Ruco; Arianna Di Napoli; Giuseppe Mesiti; Luigi Aurisicchio; Alberto Ricci; Salvatore Mariotta; Lara Pisani; Claudio Andreetti; Giuseppe Viglietto; Erino A Rendina; Maria Rosaria Giovagnoli; Gennaro Ciliberto
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.